GEHC
GE HealthCare Technologies Inc
GE HealthCare Technologies Inc historical holders
total: 6
Dodge & Cox Stock Fund GE HealthCare Technologies Inc transactions over time
- Total transactions:
- 7
- New positions:
- 1
- Added:
- 4
- Reduced:
- 2
- Held since:
- 2023 Q1
- Held for:
- 13 quarters
- Latest activity:
- 2025 Q4
Dodge & Cox Stock Fund has been an institutional investor in GE HealthCare Technologies Inc (GEHC) since 2023 Q1. According to 2026 Q1 report, Dodge & Cox Stock Fund holds 21,100,966 shares with a market value of roughly $1.50B representing 1.31% of their equity portfolio. The fund/company first acquired GEHC in 2023 Q1, initially purchasing about 9.85M shares. Since the initial investment, Dodge & Cox Stock Fund has made 6 more transactions in this position.
Does Dodge & Cox Stock Fund still hold GEHC?
Yes, Dodge & Cox Stock Fund continues to hold GE HealthCare Technologies Inc (GEHC). According to their 2026 Q1 report, they maintain a position of 21,100,966 shares valued at approximately $1.50B, representing 1.31% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in GEHC?
Dodge & Cox Stock Fund first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q1 at the reported quarter-end price of $82.03 per share, acquiring 9,846,866 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for GEHC?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for GE HealthCare Technologies Inc (GEHC) is approximately $79.43 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $79.43
- Weighted AVG sell price:
- $70.46
GEHC transactions history by Dodge & Cox Stock Fund
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
1.45%
|
21,100,966
|
$82.02
|
$1,730,701,231
|
+18.06% (+3,227,393)
|
+0.22%
|
|
2025 Q3
|
1.12%
|
17,873,573
|
$75.10
|
$1,342,305,332
|
+18.73% (+2,819,507)
|
+0.18%
|
|
2025 Q2
|
0.95%
|
15,054,066
|
$74.07
|
$1,115,054,669
|
+40.73% (+4,356,800)
|
+0.28%
|
|
2024 Q4
|
0.75%
|
10,697,266
|
$78.18
|
$836,312,256
|
-0.10% (-10,700)
|
-0%
|
|
2023 Q3
|
0.79%
|
10,707,966
|
$68.04
|
$728,570,007
|
-0.32% (-34,131)
|
-0%
|
|
2023 Q2
|
0.94%
|
10,742,097
|
$81.24
|
$872,687,960
|
+9.09% (+895,231)
|
+0.08%
|
|
2023 Q1
|
0.91%
|
9,846,866
|
$82.03
|
$807,738,418
|
new
|
+0.91%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.